NASDAQ:INBX | Profit Breakdown | Inhibrx Biosciences, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2023-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$0.00-$32.15M-$36.65M-$36.65M
2026-03-31-$30.93M-$33.44M-$33.44M
2025-12-31$0.00-$30.92M-$32.83M-$32.83M
2025-09-30$0.00-$33.81M-$35.26M-$35.26M
2025-06-30$1.3M-$27.39M-$28.65M-$28.65M
2025-03-31$0.00-$42.9M-$43.31M-$43.31M
2024-12-31$100,000.00-$49.93M-$47.87M-$47.87M
2024-09-30$0.00-$46.8M-$43.86M-$43.86M
2024-06-30$100,000.00-$160.9M$1.86B$1.86B
2024-03-31$0.00-$73.83M-$78.71M-$78.71M
2023-12-31$1.63M-$88.29M-$91.97M-$93.6M
2023-09-30$119,000.00-$45.83M-$51.79M-$51.79M
2023-06-30$30,000.00-$41.34M-$47.05M-$47.05M
2023-03-31-$48.92M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$1.3M-$135.03M-$140.05M-$140.06M
2024-12-31$200,000.00-$331.45M$1.69B$1.69B
2023-12-31$1.8M-$219.22M-$239.72M-$241.36M